TCTMD

Talking Points

Science EN ↓ 208 episodes

A selection of the best interviews conducted by physician leaders and recorded at cardiology conferences around the globe.06f763f0-76e5-11f0-bb7c-8557ae1d8a8b

Author

TCTMD

Episodes

Episode 180: The VALOR-HCM Trial 02.08.2023 9:35

Milind Desai and C. Michael Gibson compare the results of mavacamten for severe obstructive hypertropic cardiomyopathy with the typical treatments of surgical septal myectomy or alcohol ablation.

Episode 179: The SODIUM-HF Study 12.07.2023 10:57

Justin Ezekowitz and C. Michael Gibson look at a sodium-reducing dietary intervention and its effects on patients with HF.

Episode 178: The COMPLETE Trial 05.07.2023 7:44

Shamir Mehta and C. Michael Gibson discuss how complete revascularization affects angina-related quality of life in patients with STEMI.

Episode 177: The EDIT-CMD Trial 14.06.2023 10:45

Tijn Jansen, Suzette Elias-Smale, and C. Michael Gibson discuss whether diltiazem improves coronary vasomotor dysfunction in patients with angina and nonobstructive coronary artery disease.

Episode 176: The IVVE Trial 24.05.2023 7:21

Mark Loeb and C. Michael Gibson discuss whether the influenza vaccine can reduce adverse vascular events among patients with HF.

Episode 175: The METEORIC-HF Trial 17.05.2023 8:53

Gregory Lewis and C. Michael Gibson discuss how omecamtiv mecarbil affects exercise tolerance in patients with chronic HFrEF.

Episode 174: The DIAMOND Trial 03.05.2023 7:50

Javed Butler and C. Michael Gibson discuss using patiromer to manage hyperkalemia in patients with HFrEF who are taking RAAS inhibitors.

Episode 173: MAVA-LTE: The EXPLORER-LTE Cohort 19.04.2023 8:13

Florian Rader and C. Michael Gibson look at cumulative outcomes for patients with obstructive hypertrophic cardiomyopathy treated with mavacamten.

Episode 172:The PACIFIC-AF Study 05.04.2023 7:54

Manesh Patel and C. Michael Gibson discuss the results of a phase II trial comparing the safety profiles of asundexian versus apixaban in patients with atrial fibrillation.

Episode 171: The PROTECT Trial 22.03.2023 7:19

Daniel Sessler and C. Michael Gibson compare myocardial injury rates following mild hypothermia versus aggressive warming during noncardiac surgery.

Episode 170: The ADAPT-TAVR Trial 08.03.2023 14:37

Duk-Woo Park and C. Michael Gibson discuss edoxaban vs dual antiplatelet therapy for valve thrombosis and cerebral thromboembolism after TAVI.

Episode 169: The FLAVOUR Trial 01.03.2023 16:44

Bon-Kwon Koo and C. Michael Gibson compare the efficacy of FFR-guided and IV ultrasound-guided PCI for coronary artery stenosis.

Episode 168: The GIPS-IV Study 08.02.2023 8:09

Marie-Sophie de Koning and C. Michael Gibson discuss whether the use of sodium thiosulfate after STEMI helps preserve cardiac function.

Episode 167: The Spyral HTN-ON MED Pilot Study 01.02.2023 5:00

Felix Mahfoud and C. Michael Gibson examine the efficacy of renal denervation for long-term BP reduction in patients taking antihypertensive medication.

Episode 166: Chronic Kidney Disease In CANTOS 11.01.2023 7:23

Paul Ridker and C. Michael Gibson discuss a secondary analysis from CANTOS looking at residual inflammatory and cholesterol risks based on chronic kidney disease status.

Episode 165: The STAR-T/D Trial 04.01.2023 4:21

Michael Mack and C. Michael Gibson discuss a novel method for extracting antithrombotics from the blood during CABG.

Episode 164: The LOOP Study for AF Screening 14.12.2022 16:31

C. Michael Gibson and Jesper Hastrup Svendsen discuss the use of implantable loop recorders to prevent stroke in AF.

Episode 163: The ENVISAGE-TAVI AF Trial 07.12.2022 7:18

C. Michael Gibson and George Dangas discuss edoxaban vs vitamin K antagonists after TAVI in patients with atrial fibrillation.

Episode 162: The FIGARO-DKD Trial 23.11.2022 7:30

Episode 162: The FIGARO-DKD Trial by TCTMD

Episode 161: AMULET-IDE: One-Year Outcomes 09.11.2022 6:45

C. Michael Gibson and Dhanunjaya Lakkireddy discuss device success and thrombus risk in Amulet versus Watchman for LAA closure.

Episode 160: Shock Classification Gets an Update 02.11.2022 4:06

C. Michael Gibson and Timothy Henry discuss key updates to the SCAI SHOCK classifications.

Episode 159: MICHELLE: Rivaroxaban in COVID-19 19.10.2022 7:37

C. Michael Gibson and Renato Lopes discuss extended DOAC prophylaxis in medically ill, hospitalized patients with COVID-19.

Episode 158: The RIPCORD 2 Trial 05.10.2022 10:33

C. Michael Gibson and Nicholas Curzen discuss whether routine pressure-wire assessment influences the use of coronary angiography for diagnosing chest pain.

Episode 157: PARTNER 3: Two-Year Economic Outcomes 14.09.2022 4:33

C. Michael Gibson and David Cohen discuss cost implications of this TAVI versus SAVR randomized trial.

Episode 156: The IAMI Trial 07.09.2022 8:19

C. Michael Gibson and Ole Fröbert discuss the potential for influenza vaccination in post-MI patients.